Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.950 CAD | -2.01% | -1.52% | -6.25% |
08-20 | McCoy Global Secures TSX Approval for Normal Course Issuer Bid | MT |
08-20 | McCoy Global Brief: Announcing Approval of Normal Course Issuer Bid | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 53.39M | 38.67M | 32.8M | 52.43M | 69.69M | |||||
Total Revenues | 53.39M | 38.67M | 32.8M | 52.43M | 69.69M | |||||
Cost of Goods Sold, Total | 37.06M | 30.72M | 23.65M | 36.66M | 46.86M | |||||
Gross Profit | 16.33M | 7.95M | 9.14M | 15.76M | 22.83M | |||||
Selling General & Admin Expenses, Total | 11.16M | 7.34M | 7.03M | 8.32M | 11.02M | |||||
R&D Expenses | 3.38M | 2.22M | 1.99M | 2.96M | 4.07M | |||||
Other Operating Expenses, Total | 14.54M | 9.56M | 9.03M | 11.28M | 15.1M | |||||
Operating Income | 1.78M | -1.61M | 116K | 4.49M | 7.73M | |||||
Interest Expense, Total | -806K | -1.1M | -860K | -788K | -743K | |||||
Interest And Investment Income | 142K | 94K | 17K | 17K | 403K | |||||
Net Interest Expenses | -664K | -1.01M | -843K | -771K | -340K | |||||
Currency Exchange Gains (Loss) | -226K | -315K | -143K | -49K | -284K | |||||
Other Non Operating Income (Expenses) | -576K | - | -25K | -53K | -44K | |||||
EBT, Excl. Unusual Items | 319K | -2.93M | -895K | 3.62M | 7.06M | |||||
Restructuring Charges | - | -178K | - | - | - | |||||
Merger & Related Restructuring Charges | -240K | -196K | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | 154K | 121K | 192K | 4.14M | 24K | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | - | 1.02M | 4.78M | 36K | - | |||||
EBT, Incl. Unusual Items | 233K | -2.17M | 4.08M | 7.79M | 7.09M | |||||
Income Tax Expense | - | 9K | - | -974K | 558K | |||||
Earnings From Continuing Operations | 233K | -2.18M | 4.08M | 8.76M | 6.53M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 233K | -2.18M | 4.08M | 8.76M | 6.53M | |||||
Net Income - (IS) | 233K | -2.18M | 4.08M | 8.76M | 6.53M | |||||
Net Income to Common Incl Extra Items | 233K | -2.18M | 4.08M | 8.76M | 6.53M | |||||
Net Income to Common Excl. Extra Items | 233K | -2.18M | 4.08M | 8.76M | 6.53M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.01 | -0.08 | 0.15 | 0.31 | 0.23 | |||||
Basic EPS - Continuing Operations | 0.01 | -0.08 | 0.15 | 0.31 | 0.23 | |||||
Basic Weighted Average Shares Outstanding | 27.52M | 27.7M | 28.01M | 28.32M | 28.39M | |||||
Net EPS - Diluted | 0.01 | -0.08 | 0.14 | 0.31 | 0.23 | |||||
Diluted EPS - Continuing Operations | 0.01 | -0.08 | 0.14 | 0.31 | 0.23 | |||||
Diluted Weighted Average Shares Outstanding | 27.92M | 27.7M | 28.36M | 28.72M | 28.39M | |||||
Normalized Basic EPS | 0.01 | -0.07 | -0.02 | 0.08 | 0.16 | |||||
Normalized Diluted EPS | 0.01 | -0.07 | -0.02 | 0.08 | 0.16 | |||||
Dividend Per Share | - | - | - | - | 0.03 | |||||
Payout Ratio | - | - | - | - | 8.5 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.73M | 900K | 2.43M | 6.82M | 10.68M | |||||
EBITA | 1.94M | -775K | 894K | 5.63M | 9.54M | |||||
EBIT | 1.78M | -1.61M | 116K | 4.49M | 7.73M | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | - | -0.42 | - | -12.5 | 7.87 | |||||
Total Current Taxes | - | 9K | - | 111K | 745K | |||||
Total Deferred Taxes | - | - | - | -1.08M | -187K | |||||
Normalized Net Income | 199K | -1.83M | -559K | 2.26M | 4.41M | |||||
Interest on Long-Term Debt | 374K | 466K | 386K | 356K | 507K | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 2.22M | 1.42M | 1.44M | 1.78M | 2.42M | |||||
General and Administrative Expenses | 8.94M | 5.92M | 5.6M | 6.53M | 8.6M | |||||
Research And Development Expense From Footnotes | 3.38M | 2.22M | 1.99M | 2.96M | 4.07M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | 189K | 273K | 592K | 566K | 1.31M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 189K | 273K | 592K | 566K | 1.31M |